You are here

  • Home
  • Impact
  • Publications
  • Development of a drug-response modeling framework to identify cell line derived translational biomarkers that can predict treatment of Erlotinib or Sorafenib

Development of a drug-response modeling framework to identify cell line derived translational biomarkers that can predict treatment of Erlotinib or Sorafenib

Li, B., Shin, H., Glubekyan, G., Pustovalova, O., Nikolsky, Y., Hope, A., ... Schu, M. (2015). Development of a drug-response modeling framework to identify cell line derived translational biomarkers that can predict treatment of Erlotinib or Sorafenib. PLoS One.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Double-shelled ZnSnO3 hollow cubes for efficient photocatalytic degradation of antibiotic wastewater
Article

Substance use disorder treatment services for pregnant and postpartum women in residential and outpatient settings
Article

Risk and protective factors of identity theft victimization in the United States
Article

Validation of the NIDA-modified ASSIST as a screening tool for prenatal drug use in an urban setting in the United States.

RTI uses cookies to offer you the best experience online. By continuing to use our website, you agree to the use of cookies. If you would like to know more about cookies and how to manage them please view our Privacy Policy. Learn More.

Got it!